BRA
BMY icon

Blue Rock Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Blue Rock Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-126,737
Closed -$7.64M – 38
2020
Q3 		$7.64M Buy
+126,737
New +$7.63M 6.59% 2

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Blue Rock Advisors's BMY Position: Q4 2020 in Review

Blue Rock Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 126,737 shares — an estimated $7.64M sold.

Blue Rock Advisors first reported a position in BMY in Q3 2020 and held it in 1 quarter. The position peaked at $7.64M in Q3 2020. 2,359 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Blue Rock Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • Blue Rock Advisors sold 126,737 Bristol-Myers Squibb shares in Q4 2020, an estimated $7.64M.
  • Blue Rock Advisors first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 1 quarter.
  • Blue Rock Advisors's Bristol-Myers Squibb position peaked at $7.64M in Q3 2020.
  • 2,359 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Blue Rock Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.